Standard

The Health-Economic Evaluation of Risdiplam in Patients with Spinal Muscular Atrophy. / Kolbin, A.; Kurylev, A.; Balykina, Y.; Proskurin, M.; Mishinova, S.

In: Value in Health, Vol. 25, No. 1S, POSB42 , 01.2022, p. S68.

Research output: Contribution to journalMeeting Abstractpeer-review

Harvard

Kolbin, A, Kurylev, A, Balykina, Y, Proskurin, M & Mishinova, S 2022, 'The Health-Economic Evaluation of Risdiplam in Patients with Spinal Muscular Atrophy', Value in Health, vol. 25, no. 1S, POSB42 , pp. S68.

APA

Kolbin, A., Kurylev, A., Balykina, Y., Proskurin, M., & Mishinova, S. (2022). The Health-Economic Evaluation of Risdiplam in Patients with Spinal Muscular Atrophy. Value in Health, 25(1S), S68. [POSB42 ].

Vancouver

Kolbin A, Kurylev A, Balykina Y, Proskurin M, Mishinova S. The Health-Economic Evaluation of Risdiplam in Patients with Spinal Muscular Atrophy. Value in Health. 2022 Jan;25(1S):S68. POSB42 .

Author

Kolbin, A. ; Kurylev, A. ; Balykina, Y. ; Proskurin, M. ; Mishinova, S. / The Health-Economic Evaluation of Risdiplam in Patients with Spinal Muscular Atrophy. In: Value in Health. 2022 ; Vol. 25, No. 1S. pp. S68.

BibTeX

@article{52f4b97476bc409d82a0dd9116ca3266,
title = "The Health-Economic Evaluation of Risdiplam in Patients with Spinal Muscular Atrophy",
author = "A. Kolbin and A. Kurylev and Y. Balykina and M. Proskurin and S. Mishinova",
year = "2022",
month = jan,
language = "English",
volume = "25",
pages = "S68",
journal = "Value in Health",
issn = "1098-3015",
publisher = "Elsevier",
number = "1S",
note = "null ; Conference date: 30-11-2021 Through 03-12-2021",
url = "https://www.ispor.org/conferences-education/conferences/past-conferences/ispor-europe-2021",

}

RIS

TY - JOUR

T1 - The Health-Economic Evaluation of Risdiplam in Patients with Spinal Muscular Atrophy

AU - Kolbin, A.

AU - Kurylev, A.

AU - Balykina, Y.

AU - Proskurin, M.

AU - Mishinova, S.

PY - 2022/1

Y1 - 2022/1

UR - https://www.valueinhealthjournal.com/article/S1098-3015(21)02110-0/fulltext

M3 - Meeting Abstract

VL - 25

SP - S68

JO - Value in Health

JF - Value in Health

SN - 1098-3015

IS - 1S

M1 - POSB42

Y2 - 30 November 2021 through 3 December 2021

ER -

ID: 93827260